Tuberculosis infection rates in Uganda have increased due to the AIDS epidemic in the country, but the scarcity of health centres and over-crowding in camps for the displaced are also to blame, officials said. "The rise in the infection rate is mainly because of HIV. In many countries with a high prevalence of HIV/AIDS, TB cases have gone up because HIV has attacked and weakened the body’s defence systems, which would keep at bay widespread TB infections,” Joseph Imoko, the World Health Organisation (WHO) national professional officer for TB in Uganda said.
Equity and HIV/AIDS
HIV and AIDS has always been one of the most thoroughly global of diseases. In the era of widely available anti-retroviral therapy (ART), it is also commonly recognised as a chronic disease that can be successfully managed on a long-term basis. This article examines the chronic character of the HIV and AIDS pandemic and highlights some of the changes we might expect to see at the global level as HIV is increasingly normalised as ‘just another chronic disease’. The article also addresses the use of this language of chronicity to interpret the HIV and AIDS pandemic and calls into question some of the consequences of an uncritical acceptance of concepts of chronicity.
Conflict has long been assumed to contribute significantly to the spread of HIV infection. However, new research is casting doubt on this assumption. Studies from Africa suggest that conflict does not necessarily predispose to HIV transmission and indeed, there is evidence to suggest that recovery in the ‘post-conflict’ state is potentially dangerous from the standpoint of HIV transmission. There has also been concern that high rates of HIV infection among many of the militaries of sub-Saharan Africa poses a threat to regional security. However, data is lacking on this. These issues are of vital importance for HIV programming and health sector development in conflict and ‘post-conflict’ societies and will constitute formidable challenges to the international community. Further research is required to better inform the discussion of HIV, conflict and security in sub-Saharan Africa.
The GAIN Issues Brief is being launched in response to a perceived gap in current news analysis on the issues of HIV/AIDS, its implications for democracy and governance in Africa, and the challenges of ensuring that the response to HIV/AIDS is consonant with democratic principles. This Issues Brief is a product of the African Civil Society Governance and AIDS Initiative (GAIN), launched in October 2003. The aim of this Issues Brief is to provide civil society activists, journalists and policymakers with a concise analytical digest of developments in the field of HIV/AIDS, governance and democracy.
A meeting to address issues around HIV and men who have sex with men went ahead as scheduled in Addis Ababa, Ethiopia, on 3 December 2011, despite protests and calls for its cancellation by local religious leaders. The meeting - held a day before the opening of the 16th International Conference on AIDS and Sexually transmitted infections in Africa (ICASA) - was organized by the South African-based NGO, African Men for Sexual Health and Rights (AMSHeR). Originally due to be held at a local hotel, the venue quietly shifted to the UN compound in Addis Ababa. According to participants, it attracted more than 150 participants from 25 African countries, and focused on addressing the problems MSM faced in accessing HIV services. Speakers included UNAIDS executive director, Michel Sidibe. Before the meeting, four religious leaders had called a press conference to denounce it. Ethiopia's Minister of Health, Tedros Adhanom Ghebreyesus, persuaded them to cancel the press conference. Even at the new venue, there were hundreds of protesters outside for half the day, said one participant, Homosexuality is illegal in Ethiopia and punishable by between three and 10 years in prison. While the government allowed the meeting to go ahead, gay rights activists doubt it will lead to a positive change for MSM in Ethiopia.
Based on field experience in environments with limited resources, this paper aims to illustrate the various strategies developed by Medicins sans Frontiers (MSF) to simplify patient screening and follow-up in order to increase access to anti-retroviral treatment. These include decentralising and streamlining treatment protocols, transferring skills, beginning treatment earlier, using new biological monitoring tools, gaining access to new drugs with fewer side effects, and not leaving out patients with complicated cases. The new strategies tend to place more responsibility on patients and simplify their treatment. Medical teams can then focus on treating the most complicated cases. Decentralising medical care and delegating responsibilities to less-qualified personnel (task shifting) are crucial, the paper argues. By giving patients more autonomy and making them responsible for their health, this paper argues, health facilities can spread out their medical consultations to every six months and thus reduce their workload. Simplifying medical follow-up may be achieved by decentralising and streamlining patient care and ensuring that two essential blood tests are available to patients - measuring the CD4 cell count, and the viral load.
This paper examines the history of HIV/AIDS in Kenya since it was first diagnosed in the country. The introduction of highly active antiretroviral therapy (HAART) has dramatically improved the prognosis for individual patients with AIDS, but education and changing attitudes towards condoms have led to a progressive fall in incidence, so that the worst of the epidemic may now be over. Limited personal experience suggests that steroids may also have a role in salvaging critically ill AIDS patients, who need to be treated as emergencies. With an educated public and attention to alternative routes of infection such as blood transfusion, the epidemic should be increasingly contained during the next 25 years, and may even fizzle out.
Individuals coinfected with HIV and hepatitis C virus are more likely to develop end-stage liver disease (ESLD) compared to patients with hepatitis C virus, alone, according to a study presented at the Sixteenth International AIDS Conference in Toronto on August 15th. However, the investigators found that coinfected patients who achieved a sustained response to hepatitis C therapy were no more likely to progress to end stage liver disease than their hepatitis C monoinfected peers. This could have important implications for prioritising recipients of hepatitis C therapy in resource-poor settings.
Failure to properly manage HIV strategies for employees has led to some workplace programmes being closed down, as audits have revealed unacceptable costs. Individual companies, communities and the South African economy are under threat if companies do not initiate expertly managed, independent and outsourced HIV programmes for their employees. Failure to expertly manage programmes effectively means money spent on them is wasted, with consequent negative impacts on the individuals concerned, and workplace productivity and morale. Companies that try to cut corners are reported to be undermining themselves, as well as the entire local treatment initiative.
This is the first study to report malaria as a risk factor of concurrent HIV infection at the population level. The authors examined the association between malaria and HIV prevalence in east sub-Saharan Africa. They used large nationally representative samples of 19,735 sexually active adults from the 2003–04 HIV and AIDS indicator surveys conducted in Kenya, Malawi and Tanzania, as well as the Atlas Malaria Project, and analysed the relationship between malaria and HIV prevalence, adjusting for important socio-economic and biological cofactors. They found that individuals who live in areas with a high malaria parasite rate are about twice as likely to be HIV positive compared with individuals who live in areas with a low parasite rate. The authors argue that these findings emphasise the need for field studies focused on quantifying the interaction among parasitic infections and risk of HIV infection, as well as studies to explore the impact of control interventions. Public health programmes in the region should be focused on reducing malaria transmission, especially in HIV-infected individuals.
